Cannabis researcher appointed to Order of Canada

Dr Ernest Small is one of 125 new recipients of the honour this year

A cannabis researcher is among 125 new appointments to the Order of Canada for 2017 from the Governor General.

Dr Ernest Small, is a principal research scientist with the Canadian Ministry of Agriculture and has written several books and hundreds of papers on different plants, including numerous pieces on cannabis. He has also consulted with the Canadian government, as well as governments in the US on cannabis legislation.

Dr Small spent the first 10 years of his career focussing on cannabis, worked with the Le Dain Commission, and helped Health Canada with botanical research and the cultivation of the supply of medicinal cannabis in the 1970’s.

The Governor General’s announcement was made on Friday, December 29. The Order of Canada was created in 1967, one of Canada’s highest civilian honours, to recognize outstanding achievement, dedication to the community and service to the nation. Nearly 7,000 people have received the Order.

Small’s book, Cannabis: A Complete Guide, bills itself as a guide for “scientists, doctors, economists, students, industries, and governments to evaluate risks and benefits of all aspects of cannabis,” with more than 1,700 literature citations. Some of Small’s papers on cannabis/hemp include looking at cannabis classifications, breeding, seeds, and more.

He is currently working on a project that looks at the seeds of medicinal cannabis sativa, as well as several other non cannabis related botanical projects.

Lift had a chance to ask Dr Small a few questions about his thoughts on this historic appointment and where he sees the future of cannabis going, below:

Lift: How does it feel to have your work recognized by this prestigious award? 

Dr Ernest Small: "Great! Scientists such as myself work for the most part in obscurity, making great efforts to achieve small advances. Most of what we do is of no interest to the public, even with a hot topic like cannabis. But what we do is genuinely important in the long run, and it’s extremely satisfying to know that from time to time it’s recognized."

Lift: What are some current projects you are working on in regard to cannabis sativa?

ES: "Mostly I’m writing up completed projects, and proposing new ones. At the moment, the field is developing so rapidly that the “system” (i.e. provision of research funds) is having trouble adjusting."

Lift: What do you think the future holds for cannabis-related research in a post-legalization Canada?

ES: "The medical, recreational, and industrial aspects have been suppressed for so long, that even with the explosives growth in research there’s a huge deficit of knowledge.

"Many reputable researchers and businesspeople have been very reluctant to get into the field because of the stigma, but that will rapidly change.

"Unfortunately, as in all business cycles, copycats and dreamers are going to gum up progress for a while, but eventually stability will be achieved – given what happened after hemp was first authorized, this will take about 5 years.

"The future is always unpredictable, but I expect that recreational aspects will approach but not equal the stature of alcoholic beverages, medical aspects will be significant but I doubt that the most optimistic prospects (“cure for cancer” etc.) will be realized, food aspects will steadily become more widespread and profitable, and there will be minor oilseed industrial applications. All in all, cannabis is destined to become a multibillion dollar staple of the future, greatly increasing employment (including research)."

Featured image by Zill Niazi.

In this article

Join the Conversation

1 comment

  1. Ja Reply

    Very interesting, he would have been a good witness during the HESA witness testimonies.

    Looking some points from his book, a lot of these should have been educated to all members, but many were not. I even think the book should have been mandatory, educational reading for all of them.

    The medicinal importance of combining THC and CBD
    Comparative therapeutic value of pure chemicals and herbal mixtures
    Bias against euphoric medicines
    Bias in research on medical marijuana
    Cannabiphobia and the cultural war on marijuana
    Prescription drugs vs. over-the-counter herbals
    Clarification of the term "psychoactive"
    Clarification of the term "drug"

    Although, Phillipe Lucas, Jonathan Page and a couple others did have some great points input, just that most of it went into one ear and out the other, to most members it seems.

    And some other great points from his book that didn't seem to get much or any mention during the meetings:

    Endocannabinoids
    Endocannabinoid receptors
    Inter-cellular communication involving endocannabinoids
    The broad range of compounds affecting the endocannabinoid system
    Effects of cannabinoids on non-endocannabinoid physiological systems
    Medical importance of the endocannabinoid system
    Extensive activity of the endocannabinoid system limits targeted therapy
    Evolution of the endocannabinoid system & potential for non-human patients
    The endocannabinoid system in relation to the lack of overdose marijuana mortality
    LD50 (median lethal dose)
    ...

    The great irony: from counterculture narcotic to mass-marked commodity
    How major crops harm the world and why Cannabis sativa can be beneficial
    The incredibly parallel histories of Cannabis and its closest relative, Humulus (hop)
    ...

    And to think, people still use dispensaries for these reasons, but oh... the 'organized' crime, vs the 'authorized crime'.. they must keep immorally raiding and arresting, to stop people from accessing their herbal medicine, beneficial for all these reasons and more:

    Alzheimer’s disease and other forms of dementia
    Amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease)
    Anorexia & appetite loss
    Arthritis & rheumatism
    Brain injury
    Cancer
    Cardiovascular diseases
    Atherosclerosis
    Hypertension
    Ischemia
    Diabetes
    Epilepsy
    Fibromyalgia
    Gastrointestinal diseases
    Glaucoma
    Headache
    Migraine
    Human immunodeficiency virus & acquired immunodeficiency syndrome
    Huntington’s disease
    Insomnia
    Liver disease
    Morning sickness
    Multiple sclerosis and spasticity
    Neurodegenerative diseases
    Neuropathy
    Obesity
    Osteoporosis
    Pain
    Parkinson’s disease
    Psychiatric disorders
    Addiction
    Anxiety
    Autism spectrum disorder
    Attention deficit/hyperactivity disorder (ADHD)
    Bipolar disorder
    Depression
    Posttraumatic stress disorder
    Schizophrenia
    Skin conditions
    Acne & seborrhea
    Alopecia
    Dermatitis
    Hirsutism
    Pruritis
    Psoriasis
    Scleroderma
    Tourette’s syndrome
    Medical applications of specific cannabinoids
    Tetrahydrocannabinol
    Cannabidiol
    Arthritis
    Cancer
    Diabetes
    Epilepsy
    Inflammatory bowel diseases
    Nausea and vomiting
    Neurodegenerative diseases
    Pain
    Psychiatric disorders
    ...